Back to Search Start Over

Inefficacy of Platelet Transfusion in a Heart Transplant Patient Under Continuous Ticagrelor

Authors :
Huyen T. Tran
Nicolas D'Ostrevy
Kasra Azarnoush
Dat T. Pham
Laura Filaire
Lionel Camilleri
Service chirurgie cardio-vasculaire
CHU Clermont-Ferrand
service de chirurgie thoracique
Centre Jean Perrin [Clermont-Ferrand] (UNICANCER/CJP)
UNICANCER-UNICANCER
Cardiovascular treatment center
E Hopital Hanoi
Department Cardiology
Saint Paul general Hospital
Unité de Nutrition Humaine (UNH)
Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne [2017-2020] (UCA [2017-2020])
Centre Hospitalier Universitaire de Clermont-Ferrand
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne
Unité de Nutrition Humaine - Clermont Auvergne (UNH)
Institut National de la Recherche Agronomique (INRA)-Université Clermont Auvergne (UCA)
chirurgie thoracique et cardio-vasculaire
Service de chirurgie cardiaque
Institut Pascal - Clermont Auvergne (IP)
Sigma CLERMONT (Sigma CLERMONT)-Université Clermont Auvergne (UCA)-Centre National de la Recherche Scientifique (CNRS)
Source :
Journal of Cardiothoracic and Vascular Anesthesia, Journal of Cardiothoracic and Vascular Anesthesia, WB Saunders, 2017, in press (5), ⟨10.1053/j.jvca.2017.02.180⟩, Journal of Cardiothoracic and Vascular Anesthesia, WB Saunders, 2017, in press, ⟨10.1053/j.jvca.2017.02.180⟩, Journal of Cardiothoracic and Vascular Anesthesia, WB Saunders, 2017, 31 (5), pp.1776-1778. ⟨10.1053/j.jvca.2017.02.180⟩
Publication Year :
2017
Publisher :
Elsevier BV, 2017.

Abstract

Antiplatelet agents have a predominant role in the therapeutic treatment of acute coronary syndrome (ACS) and myocardial infarction. Recently, ticagrelor has been incorporated in the European Society of Cardiology guidelines for the management of ACS with ST elevation and non-ST elevation.1 The AHA/ACC guidelines further advocate the choice of ticagrelor over clopidogrel in patients with ACS with non-ST elevation treated with an early invasive strategy.2 In fact, major studies have proven the benefits of ticagrelor on cardiovascular death, myocardial infarction, and stroke without an increase in major bleeding risk

Details

ISSN :
10530770 and 15328422
Volume :
31
Database :
OpenAIRE
Journal :
Journal of Cardiothoracic and Vascular Anesthesia
Accession number :
edsair.doi.dedup.....7f81359226e5e22695cf64e921cb2a0a
Full Text :
https://doi.org/10.1053/j.jvca.2017.02.180